Parkinson's Trial NCT03508960
Identify non hereditary progression factors
- Trial ID
- NCT03508960
- Official Title
- The Chinese Early-onset Parkinson's Disease Registry
- Goal
- Identify non hereditary progression factors
- Status
- RECRUITING
- Sponsor
- Xiangya Hospital of Central South University
- Study Type
- OBSERVATIONAL
- Enrollment
- 3000 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to build a large registry to better understand early-onset Parkinson's in Chinese patients, especially how symptoms begin, change over time, and what non-hereditary factors might be linked to the disease. The approach is observational, enrolling up to 3,000 people diagnosed by standard criteria including the UK Brain Bank, and collecting clinical data and medical history over time so researchers can map patterns, progression, and potential biomarkers. Eligible participants are adults whose Parkinson's symptoms started at age 50 or younger, diagnosed by UKBB or equivalent criteria, and who do not have a family history of PD.
Locations
- Xiangya Hospital of Central South University, Changsha, Hunan, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to build a large registry to better understand early-onset Parkinson's in Chinese patients, especially how symptoms begin, change over time, and what non-hereditary factors might be linked to the disease. The approach is observational, enrolling up to 3,000 people diagnosed by standard criteria including the UK Brain Bank, and collecting clinical data and medical history over time so researchers can map patterns, progression, and potential biomarkers. Eligible participants are adults whose Parkinson's symptoms started at age 50 or younger, diagnosed by UKBB or equivalent criteria, and who do not have a family history of PD.
- Who can participate?
- Participants must be 50 Years or younger.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 10 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.